Previous studies reported that ALKBH5 could up-regulate NANOG expression via regulating the demethylation of NANOG in different tumors, like breast cancer, oral squamous cell carcinoma and ovarian cancer [24, 44, 45]. Here, NANOG is linked to ovarian cancer.